Atrial Fibrillation Surgery Market

Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020

Report Code: MD 3960 Dec, 2015, by marketsandmarkets.com

Atrial Fibrillation (AF) is the most common type of arrhythmia that causes an irregular and often fast heart rhythm. Over the past two decades, an increasing prevalence of atrial fibrillation cases is seen across the globe. According to American Heart Association, around 33.5 million people were suffering from atrial fibrillation around the world in 2013. Furthermore, about 200,000 to 400,000 new atrial fibrillation cases are diagnosed each year in the U.S.

The global AF surgery product market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020. This market is segmented on the basis of surgical procedures into catheter ablation and surgical ablation. Catheter and surgical ablation procedures are well accepted for the treatment of atrial fibrillation. Catheter ablation holds a larger market share and is poised to grow at a CAGR of 14.5% during the forecast period.

North America was the largest contributor (in terms of monetary value) in atrial fibrillation surgery market in 2014 and will continue to dominate this market by 2020. However, Asia-Pacific is expected to be the fastest growing market for the forecast period. Regulatory policies in Asia-Pacific countries are more adaptive and business-friendly, due to the presence of less-stringent regulations and data requirements. Additionally, increasing competition in mature markets will compel atrial fibrillation catheter ablation device manufacturers to focus on emerging markets in the coming years.

The increasing number of people suffering from atrial fibrillation is the major driving force for this market. Favorable regulations are supporting the increasing use of catheter and surgical ablation treatments for AF. Larger prevalence of atrial fibrillation and lower treatment cost would support the increasing number of atrial fibrillation surgical and catheter ablation procedures in countries like France.

The major players in this market include Biosense Webster, Inc., St. Jude Medical, Inc., Medtronic, Inc., Boston Scientific Corporation, Articure, Inc., Cardiofocus, Inc., nContact, Inc., Cardima, Inc. and Biotronik SE & Co.

Scope of the Report

This report talks about the following segments in this market:

Atrial Fibrillation Surgery Market, by Product

  • Catheter Ablation
  • Surgical Ablation

Atrial Fibrillation Surgery Procedures

  • Catheter Ablation
  • Surgical Ablation

Atrial Fibrillation Surgery Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • RoE
  • Asia-Pacific
    • Japan
    • China
    • India
    • RoAP
  • Rest of the World

Atrial fibrillation (AF) is the most common type of arrhythmia that causes an irregular and often fast heart rhythm. Increasing prevalence of atrial fibrillation has been observed across the globe. According to American Heart Association, about 200,000 to 400,000 new atrial fibrillation cases are diagnosed each year in the U.S. The major factor driving this market is the increasing number of people suffering from atrial fibrillation. Favorable regulatory scenario would also propel growth in this market.

On the basis of surgical procedures this market is segmented into catheter ablation and surgical ablation. Catheter ablation procedures hold the major share in this market and are expected to grow with the highest CAGR during the forecast period of 2015 to 2020. Nevertheless, surgical ablation market is also expected to have a growth rate close to catheter ablation during the forecast period. The development in the surgical ablation technology and better results of these procedures are driving the overall number of surgical ablation procedures.

On the basis of geography, this market is segmented into: North America, Europe, Asia-Pacific and RoW. North America held the largest share in this market in 2014 and is expected to grow with the highest CAGR, including the number of procedures and revenue. On the other hand, Asia-Pacific is expected to be the fastest growing region due to the presence of a large patient population, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India.

The major players in this market include Biosense Webster, Inc., St. Jude Medical, Inc., Medtronic, Inc., Boston Scientific Corporation, Articure, Inc., Cardiofocus, Inc., nContact, Inc., Cardima, Inc. and Biotronik SE & Co. As of 2014, the atrial fibrillation catheter ablation market was highly consolidated with top 4 companies dominating the entire market. The market was dominated by Biosense Webster, Inc., a J&J company (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic, Inc. (U.S.), and Boston Scientific Corporation (U.S.).

Atrial Fibrillation Surgery Market

Table of Content

1. Introduction
    1.1. Objectives of the Study
    1.2. Assumptions & Limitations

2. Research Methodology
    2.1. Atrial Fibrillation Catheter and Surgical Procedures
    2.2. Atrial Fibrillation Catheter and Surgical Ablation Market
    2.3. Forecasting Model
    2.4. Data Triangulation
    2.5. Primary Respondent Profile

3. Atrial Fibrillation Catheter and Surgical Procedure
    3.1. Overview
    3.2. Catheter Ablation Procedures
    3.3. Surgical Ablation/Maze Procedures

4. Atrial Fibrillation Surgery Product Market
    4.1. Overview
    4.2. Catheter Ablation Product Market
    4.3. Surgical Ablation Market

5. Competitive Landscape
    5.1. Market Share Analysis: Af Catheter Ablation Market, 2014
    5.2. Market Share Analysis: Af Surgical Ablation Market, 2014
    5.3. Competitive Landscape

6. Company Profiles (Business Overview, Company at Glance, Financials, Geographic Revenue Mix, Business Revenue Mix, Product Portfolio, Key Strategies, Recent Developments)
    6.1. Biosense Webster, Inc.
    6.2. Medtronic, Inc.
    6.3. St. Jude Medical, Inc.
    6.4. Boston Scientific Corporation
    6.5. Atricure, Inc.
    6.6. Cardiofocus, Inc.
    6.7. Ncontact, Inc.
    6.8. Carima, Inc.
    6.9. Biotroik Se & Co.Kg

7. Appendix
    7.1. Additional Insights
    7.2. Secondary Resources
    7.3. Related Reports


List of Tables (18 Tables)

Table 1 Atrial Fibrillation Surgical Procedures, By Type of Procedure (Number of Procedures)
Table 2 Atrial Fibrillation Catheter Ablation Procedures, By Region (Number of Procedures)
Table 3 North America: Atrial Fibrillation Catheter Ablation Procedures, By Country (Number of Procedures)
Table 4 Europe: Atrial Fibrillation Catheter Ablation Procedures, By Country (Number of Procedures)
Table 5 Asia-Pacific: Atrial Fibrillation Catheter Ablation Procedures, By Country (Number of Procedures)
Table 6 Atrial Fibrillation Surgical Ablation/Maze Procedures, By Region (Number of Procedures)
Table 7 North America: Atrial Fibrillation Surgical Ablation/Maze Procedures, By Country (Number of Procedures)
Table 8 Europe: Atrial Fibrillation Surgical Ablation/Maze Procedures, By Country (Number of Procedures)
Table 9 Asia-Pacific: Atrial Fibrillation Surgical Ablation/Maze Procedures, By Country (Number of Procedures)
Table 10 Atrial Fibrillation Surgery Product Market, By Type of Procedure ($ Million)
Table 11 Global Atrial Fibrillation Catheter Ablation Product Market, By Region ($ Million)
Table 12 North America: Atrial Fibrillation Catheter Ablation Product Market, By Country ($ Million)
Table 13 Europe: Atrial Fibrillation Catheter Ablation Product Market, By Country ($ Million)
Table 14 Asia-Pacific: Atrial Fibrillation Catheter Ablation Product Market, By Country ($ Million)
Table 15 Atrial Fibrillation Surgical Ablation Product Market, By Region ($ Million)
Table 16 North America: Atrial Fibrillation Surgical Ablation Product Market, By Country ($ Million)
Table 17 Europe: Atrial Fibrillation Surgical Ablation Product Market, By Country ($ Million)
Table 18 Asia-Pacific: Atrial Fibrillation Surgical Ablation Product Market, By Country ($ Million)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 3960
Published ON
Dec, 2015
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Atrial Fibrillation Surgery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved